Ludwig Hantson
Director/Board Member chez HOLOGIC, INC.
Fortune : 818 590 $ au 29/02/2024
Profil
Ludwig N. Hantson occupe le poste de directeur général et de directeur chez Alexion Pharmaceuticals, Inc. Il est également membre du conseil d'administration de Hologic, Inc. et de la Biotechnology Innovation Organization. Le Dr Hantson a précédemment occupé le poste de président de la division des sciences biologiques chez Baxter International, Inc. de président-directeur général chez Synovis Life Technologies, Inc. et de président chez Baxter BioScience Corp. (toutes deux filiales de Baxter International, Inc.), directeur chez Johnson & Johnson, président de Pharma Canada chez Novartis AG et directeur général de Pharma Amérique du Nord chez Novartis Pharmaceuticals Corp. (une filiale de Novartis AG), président, directeur général et administrateur de Baxalta, Inc. et directeur de Smith & Nephew NV. Ludwig N. Hantson a obtenu un doctorat et un diplôme d'études supérieures de l'Université catholique de Louvain.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
HOLOGIC, INC.
0,00% | 07/03/2024 | 11 092 ( 0,00% ) | 818 590 $ | 29/02/2024 |
Postes actifs de Ludwig Hantson
Sociétés | Poste | Début |
---|---|---|
HOLOGIC, INC. | Director/Board Member | 21/11/2018 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Anciens postes connus de Ludwig Hantson
Sociétés | Poste | Fin |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Chief Executive Officer | 21/07/2021 |
BAXALTA INC | Chief Executive Officer | 03/06/2016 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/05/2010 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2010 |
Formation de Ludwig Hantson
Université Catholique de Louvain | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
HOLOGIC, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
NOVARTIS AG | Health Technology |
Entreprise privées | 7 |
---|---|
Synovis Life Technologies, Inc.
Synovis Life Technologies, Inc. Medical SpecialtiesHealth Technology Synovis Life Technologies, Inc. manufactures medical devices. It markets biological and mechanical products used by surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company was founded in July 1985 and is headquartered in St. Paul, MN. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Smith & Nephew NV/SA
Smith & Nephew NV/SA Medical SpecialtiesHealth Technology Smith & Nephew NV engages in the development of medical technologies. It offers advanced wound management and advanced surgical devices. The company was founded on April 13, 2001 and is headquartered in Zaventem, Belgium. | Health Technology |